8-KRegulation FD

Elevance Health, Inc. 8-K Report, Regulation FD Disclosure (Jan 7, 2008)

Filed January 7, 2008For Securities:ELV

Summary

Elevance Health, Inc. (then known as WellPoint, Inc.) filed this Form 8-K on January 7, 2008, to disclose information related to upcoming meetings with securities analysts and investors scheduled for January 7-8, 2008. The primary purpose of these meetings was to confirm the company's ability to meet previously issued earnings per share (EPS) expectations. These expectations were initially communicated in press releases and webcasts on December 11, 2007, and October 24, 2007. This filing serves as a reiteration of confidence in the company's financial performance outlook during that period, aimed at reassuring investors and the market. The report also includes a comprehensive Safe Harbor statement under the Private Securities Litigation Reform Act of 1995. This section outlines various risks and uncertainties that could affect WellPoint's future financial results. These include factors such as government regulation, healthcare cost trends, competition, enrollment changes, the Medicare Part D program, acquisition integration risks (specifically mentioning WellChoice, Inc.), and general economic conditions. Investors are cautioned to consider these risks when evaluating the company's forward-looking statements.

Key Highlights

  • 1WellPoint, Inc. (now Elevance Health) confirms ability to meet previously issued EPS expectations.
  • 2Confirmation of EPS expectations made during upcoming analyst and investor meetings (Jan 7-8, 2008).
  • 3Reference to prior communications on EPS expectations: Dec 11, 2007 and Oct 24, 2007 press releases/webcasts.
  • 4Filing primarily for Regulation FD disclosure purposes.
  • 5Extensive Safe Harbor statement detailing numerous business and market risks.
  • 6Specific risks mentioned include government regulation, healthcare costs, competition, Medicare Part D, and acquisition integration (WellChoice).
  • 7Caution to investors regarding reliance on forward-looking statements due to inherent risks.

Frequently Asked Questions

The main purpose of this 8-K filing is to publicly disclose that WellPoint, Inc. (now Elevance Health) officers will be meeting with securities analysts and investors and will be confirming the company's ability to meet its previously announced earnings per share (EPS) expectations.

The original earnings per share expectations were set in a press release and webcast on December 11, 2007, and further detailed in a press release and conference call on October 24, 2007.

The Safe Harbor statement highlights a broad range of risks and uncertainties that could materially affect WellPoint's future results. These include regulatory changes, healthcare cost inflation, competitive pressures, changes in enrollment mix, challenges related to the Medicare Part D program, integration risks from acquisitions like WellChoice, Inc., and general economic downturns.

No, the filing explicitly states that none of the information furnished in this report shall be deemed to be 'filed' for purposes of Section 18 of the Securities and Exchange Act of 1934, nor shall it be incorporated by reference into any filing under the Securities Act of 1933.